Capsigen Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
Capsigen General Information
Description
Operator of a biotechnology firm intended to engineer novel adeno-associated virus capsids to address difficult-to-treat diseases. The company's proprietary transcription-dependent directed evolution technology eliminates background noise and identifies fully functional capsids designed to meet complex disease-specific transduction profiles, enabling researchers and scientists to test large-scale libraries and determine, based on a specific set of criteria for the delivery and treatment of the disease.
Contact Information
Website
www.capsigen.comCorporate Office
- 1010 Washington Street
- Suite 220
- Vancouver, WA 98660
- United States
Corporate Office
- 1010 Washington Street
- Suite 220
- Vancouver, WA 98660
- United States
Capsigen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Dec-2020 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Dec-2020 | Completed | Generating Revenue |
Capsigen Patents
Capsigen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260306661-A1 | Capsids and methods of targeting neurons | Pending | 01-May-2023 | ||
| AU-2024266671-A1 | Capsids and methods of targeting nuerons | Pending | 01-May-2023 | ||
| EP-4705490-A1 | Capsids and methods of targeting nuerons | Pending | 01-May-2023 | ||
| US-20250206783-A1 | Transcription-dependent directed evolution of aav capsids having enhanced tropism | Inactive | 21-Mar-2022 | ||
| WO-2023183304-A2 | Transcription-dependent directed evolution of aav capsids having enhanced tropism | Inactive | 21-Mar-2022 | C07K14/005 |
Capsigen Signals
Capsigen Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Creative Destruction Lab | Accelerator/Incubator | |||
| MP Healthcare Venture Management | Corporate Venture Capital | Minority | ||
| OHSU | University |
Capsigen FAQs
-
When was Capsigen founded?
Capsigen was founded in 2020.
-
Where is Capsigen headquartered?
Capsigen is headquartered in Vancouver, WA.
-
What is the size of Capsigen?
Capsigen has 16 total employees.
-
What industry is Capsigen in?
Capsigen’s primary industry is Biotechnology.
-
Is Capsigen a private or public company?
Capsigen is a Private company.
-
What is Capsigen’s current revenue?
The current revenue for Capsigen is .
-
Who are Capsigen’s investors?
Creative Destruction Lab, MP Healthcare Venture Management, and OHSU have invested in Capsigen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process